Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and
mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are …

Hirudin, an acidic polypeptide secreted by the salivary glands of Hirudo medicinalis (also
known as “Shuizhi” in traditional Chinese medicine), is the strongest natural specific inhibitor …

Due to the high recurrence rate and mortality of venous thrombosis, there is an urgent need
for research on antithrombotic strategies. Because of the short half‐life, poor targeting …

Nanoparticles are exclusively suitable for studying and developing potential therapies
against cardiovascular diseases (CVD) because of their size, fine-tunable properties, and …

Thrombosis is a global health issue and one of the leading factors of death. However, its
diagnosis has been limited to the late stages, and its therapeutic window is too narrow to …

Globally, the incidence of thromboembolic diseases has increased in recent years,
accompanied by an increase in patient mortality. Currently, several targeting delivery …

Complications with atherosclerosis can often lead to fatal clot formation and blood vessel
occlusion–also known as atherothrombosis. A key component to the development of …

Stroke is a major public health issue, corresponding to the second cause of mortality and the
first cause of severe disability. Ischemic stroke is the most common type of stroke …

Although nanotechnology has shown great promise for treating multiple vascular diseases
in recent years, simultaneous noninvasive detection and efficient dissolution of deep venous …

Abstract Poly (amido-amine)(PAMAM), one of the most widely studied dendrimers in the field
of drug and gene delivery, can enhance the stability of DNA and deliver it to cell cytosol; …